Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIB
2001
Trinity Biotech
TRIB
$7.86M
| $2.38M | 0.01% |
1,347
-114
| -8% | -$202K |
|
2002
Applied Industrial Technologies
AIT
$13B
| $2.35M | 0.01% |
58,150
+25,300
| +77% | +$1.03M |
|
|
MBTF
2003
DELISTED
MBT Financial Corporation
MBTF
| $2.34M | 0.01% |
342,856
+10,809
| +3% | +$69.8K |
|
|
SIFI
2004
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $2.34M | 0.01% |
171,279
+17,779
| +12% | +$228K |
|
|
NSH
2005
DELISTED
NuStar GP Holdings LLC
NSH
| $2.34M | 0.01% |
110,500
-18,471
| -14% | -$446K |
|
2006
MillerKnoll
MLKN
$1.64B
| $2.34M | 0.01% |
81,400
+50,700
| +165% | +$1.56M |
|
|
LSG
2007
DELISTED
LAKE SHORE GOLD CORP
LSG
| $2.33M | 0.01% |
2,878,898
+810,500
| +39% | +$670K |
|
2008
Consumer Portfolio Services
CPSS
$205M
| $2.32M | 0.01% |
447,200
-28,100
| -6% | -$144K |
|
2009
Lipocine
LPCN
$17M
| $2.32M | 0.01% |
10,541
-3,559
| -25% | -$747K |
|
|
BCA
2010
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
| $2.31M | 0.01% |
197,472
+17,306
| +10% | +$227K |
|
|
CHA
2011
DELISTED
China Telecom Corporation, LTD
CHA
| $2.31M | 0.01% |
49,700
-16,500
| -25% | -$823K |
|
2012
New Jersey Resources
NJR
$5.62B
| $2.31M | 0.01% |
70,000
-70,122
| -50% | -$2.15M |
|
2013
Natural Alternatives International
NAII
$13.2M
| $2.3M | 0.01% |
222,760
+23,660
| +12% | +$173K |
|
2014
Chubb
CB
$132B
| $2.3M | 0.01% |
19,700
-550,300
| -97% | -$62.3M |
|
|
SCAI
2015
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $2.3M | 0.01% |
57,827
+3,927
| +7% | +$137K |
|
|
POWR
2016
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
| $2.3M | 0.01% |
152,600
+32,600
| +27% | +$437K |
|
2017
Corcept Therapeutics
CORT
$12.1B
| $2.29M | 0.01% |
460,400
+8,200
| +2% | +$37K |
|
2018
Mitek Systems
MITK
$838M
| $2.29M | 0.01% |
+557,976
| New | +$2.24M |
|
|
TGP
2019
DELISTED
Teekay LNG Partners L.P.
TGP
| $2.29M | 0.01% |
174,300
+78,920
| +83% | +$1.72M |
|
|
NP
2020
DELISTED
Neenah, Inc. Common Stock
NP
| $2.29M | 0.01% |
36,700
-8,700
| -19% | -$561K |
|
2021
IRIDEX
IRIX
$14.3M
| $2.29M | 0.01% |
246,400
-8,500
| -3% | -$75.8K |
|
2022
SK Telecom
SKM
$14.1B
| $2.29M | 0.01% |
68,884
+11,401
| +20% | +$429K |
|
|
CYBE
2023
DELISTED
Cyberoptics Corp
CYBE
| $2.28M | 0.01% |
298,200
-900
| -0.3% | -$6.47K |
|
|
JMI
2024
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $2.28M | 0.01% |
363,100
+54,200
| +18% | +$341K |
|
2025
Willdan Group
WLDN
$1.29B
| $2.28M | 0.01% |
271,600
+5,951
| +2% | +$59.3K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.